Cargando…
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
BACKGROUND: Renal cell carcinoma (RCC) is a histopathologically and molecularly heterogeneous disease with the chromophobe subtype (chRCC) accounting for approximately 5% of all cases. The median overall survival of advanced RCC has improved significantly since the advent of tyrosine kinase inhibito...
Autores principales: | Venugopal, Balaji, Ansari, Jawaher, Aitchison, Michael, Tho, Lye Mun, Campbell, Roderick, Jones, Rob J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679738/ https://www.ncbi.nlm.nih.gov/pubmed/23688003 http://dx.doi.org/10.1186/1471-2490-13-26 |
Ejemplares similares
-
Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
por: Zardavas, Dimitrios, et al.
Publicado: (2011) -
Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus
por: Hadoux, Julien, et al.
Publicado: (2010) -
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019) -
Relating Prognosis in Chromophobe Renal Cell Carcinoma to the Chromophobe Tumor Grading System
por: Weinzierl, Elizabeth P, et al.
Publicado: (2014) -
Metastatic clear cell renal carcinoma – an unusual response
to Temsirolimus in second line therapy
por: Stanculeanu, DL, et al.
Publicado: (2016)